Valeant to hand back maker of ‘female Viagra’ to former owners
It paid $1bn for asset less than three years ago
It paid $1bn for asset less than three years ago
Three of agency’s reviewers recommended rejecting the drug, used to treat low libido
Deal comes days after final US approval for controversial drug
Flibanserin has been hailed as a cure for loss of female libido, but doubts remain
FDA panel backs ‘Viagra for women’ after two rejections and a controversial lobbying campaign
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices